|Articles|August 1, 2002
- Applied Clinical Trials-08-01-2002
Developing New Drugs in 1000 Days
Everybody wants faster cycles and and quicker turnarounds with NDAs. In the U.S., will it soon be possible to go from testing to approval in 1000 days?
Advertisement
Articles in this issue
almost 24 years ago
Cross-(Dys)Functional Teamsalmost 24 years ago
Checking In on Children, Checking Up on Filesalmost 24 years ago
eSource Reduxalmost 24 years ago
New User Fee Program Aims to Spur Drug Developmentalmost 24 years ago
Paper vs. Electronic DiariesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
3
AI-Driven Clinical Trial Recruitment and Design
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5